Search

Oral Cavity

S040

THE SUBSTANTIAL OMISSION OF INDICATED POST-OPERATIVE RADIOTHERAPY IN ADVANCED STAGE ORAL CANCER IN THE UNITED STATES: A CALL TO ACTION

Oral Cavity

Musaddiq Awan, MD1; Ken Akakpo, MD1; Becky Massey, MD1; Michael Stadler, MD1; Bruce Campbell, MD1; Monica Shukla, MD1; Christopher Schultz, MD1; Aditya Shreenivas, MD1; Stuart Wong, MD1; Evan Graboyes, MD, MPH2; Patrik Pipkorn, MD, MSCI3; Sidharth V Puram, MD, PhD3; Joseph Zenga1

1Medical College of Wisconsin; 2Medical University Of South Carolina; 3Washington University School of Medicine


S039

PROTEIN BIOMARKERS AS INDEPENDENT PREDICTORS OF PROGNOSIS AND CLINICOPATHOLOGIC OUTCOMES IN ORAL CAVITY SQUAMOUS CELL CARCINOMA

Oral Cavity

Daniel J Lee, MD; Nitin Pagedar, MD; Anand Rajan, MBBS, MD; Marisa Buchakjian, MD, PhD; Steven Sperry, MD

University of Iowa


S038

IDENTIFICATION OF OCCULT METASTATIC DISEASE VIA LYMPHOSCINTIGRAPHY GUIDED NECK DISSECTION (LSG-ND) IN N0 ORAL SQUAMOUS CELL CARCINOMA

Oral Cavity

Lisa B Earnest-Noble, MD, PhD; Rachel Lipsky; William I Kuhel, MD; David I Kutler, MD

Weill Cornell Medicine


S037

ORAL CAVITY SQUAMOUS CELL CARCINOMA TUMOR CENTER AND LEADING EDGE HAVE A TEMPORALLY STABLE, UNIQUE MICROBIOME COMPARED TO CONTRALATERAL NORMAL SITES

Oral Cavity

Carissa M Thomas, MD, PhD1; Alya Heirali, PhD2; Hedyeh Ziai, MD3; Maria Kulikova, BS, DPT2; Carolyn Barsoum, BS, MA3; Feben Alemu3; Dale Brown, MB3; John R de Almeida, MD, MSc3; David Goldstein, MD, MSc3; Patrick Gullane, MB3; Ralph Gilbert, MD3; Jonathan Irish, MD, MSc3; Douglas Chepeha, MD, MSCPH3; Bryan Coburn, MD, PhD2

1University of Alabama at Birmingham; 2Toronto General Research Institute; 3University Health Network, University of Toronto


S005

YOUNG NON-SMOKERS WITH ORAL CANCER: WHAT ARE WE MISSING AND WHY?

Oral Cavity

Cristina Valero1; Avery Yuan1; Daniella K Zanoni1; Snjezana Dogan2; Jatin P Shah1; Luc G Morris1; Richard J Wong1; Aviram Mizrachi3; Snehal G Patel1; Ian Ganly1

1Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 2Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 3Department of Otorhinolaryngology - Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel


S004

SYSTEMIC INFLAMMATION IS ASSOCIATED WITH DISEASE EXTENT AND SURVIVAL IN ORAL CAVITY SQUAMOUS CELL CARCINOMA

Oral Cavity

Brendan Coutu, MD; Dallin Christensen, MD; Evan Ryan, BS; Elizabeth Bradford Bell, MD; Weining Zhen, MD; Zafar Sayed, MD

University of Nebraska Medical Center


P526

REAL-TIME RAMAN SPECTROSCOPY IN MARGIN ANALYSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS

Oral Cavity

Chwee Ming Lim1; Chi Shu2; Kan Lin2; Zhi Wei Huang2

1Singapore General Hospital , Duke-NUS Medical School; 2National University of Singapore


P525

THE DEVELOPMENT OF FOREIGN ACCENT SYNDROME FOLLOWING ORAL CAVITY SURGERY - A CASE SERIES AND REVIEW OF THE LITERATURE

Oral Cavity

Nicole M Fowler, MD; Claudia I Cabrera, MD

University Hospitals Cleveland Medical Center


P524

POSITIVE MARGINS MATTER REGARDLESS OF SUBSEQUENT RESECTION FINDINGS

Oral Cavity

Brendan Coutu, MD; Evan Ryan, BS; Dallin Christensen, MD; Elizabeth Bradford Bell, MD; Weining Zhen; Zafar Sayed, MD

University of Nebraska Medical Center


P523

THE IMPACT OF POSITIVE MARGINS ON SURVIVAL IN ORAL CAVITY SQUAMOUS CELL CARCINOMA

Oral Cavity

Vishaal Patel1; Thomas Galloway, MD2; Jeffrey Liu, MD2

1Temple University; 2Fox Chase Cancer Center